Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from a $1.6B valuation in May 2025
Pathos AI announced on Friday that it closed a $237 million Series E financing, bringing its post‑money valuation to $3 billion, up from $1.6 billion in May 2025, according to Axios via Techmeme. The round size and valuation reflect strong investor confidence in the company’s approach.
Key points
- Pathos AI secured $237 million in a Series E round, bringing post‑money valuation to $3 billion.
- Valuation rose from $1.6 billion in May 2025 to $3 billion after the new round.
- The biotech uses AI to design oncology drugs and will use funds to expand its platform and pipeline.
The biotech leverages artificial intelligence to design oncology drugs, claiming the technology can identify promising molecular candidates faster and optimise clinical‑trial designs. Management said the new capital will be used to expand its AI platform, advance its pipeline of cancer‑treatment candidates, and scale manufacturing capabilities.
The latest raise follows earlier funding rounds that have steadily increased the company’s valuation. Analysts note that the influx of capital into AI‑driven biotech underscores a broader trend of investors betting on machine‑learning‑enhanced drug discovery to accelerate the development of new therapies.
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Business & Funding
All →- Nvidia stock drops 2.18% on AI demand and export concerns · 7 src
- OpenAI nears $30B funding round at $1.25T valuation led by UAE investors and Coatue · 9 src
- ARK Invest buys 38,110 Meta shares across three ETFs amid AI spending concerns · 1 src
- Anthropic and Hg agree to launch AI consultancy for European businesses by 2026 · 3 src
- Meta reports Q3 revenue of $64.6 billion, up 26% year over year, with AI spending rising · 12 src
Comments
via GitHub Discussions